IRMD
IRADIMED CORPORATION
Healthcare · Medical Devices · NGM
$91.84
Close 2026-05-28
✓ ETHICAL PASS

UNKNOWN MOAT
HIGH
Data Confidence: 100%
Full financial profile available
Market Cap
$1.2B
Trailing P/E
50.19
Forward P/E
39.00
Rev Growth
+12.6%
Profit Margin
27.4%
ROE
25.0%
Analyst Target
$118.00
Recommendation
NONE
About IRADIMED CORPORATION

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Ethical Screen
Business ActivityPASS
Debt RatioN/A
Cash RatioN/A
Receivables RatioN/A
Revenue Ratio (0.00%)PASS
OverallPASS
Score Ethical: 64.7
Score Valuation: 36.5
Score Quality: 88.2
Score Combined: 54.6

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation16.8
Quality97.0
Cash Flow16.1
Moat40.0
Balance Sheet50.0
Debt Purity50.0
Liquid Purity50.0
Rev Purity100.0
Compliance100.0
Tier: BRONZE · Score: 46.6 · Rank: #2773
Insider Transactions
No insider transaction data.
Top Institutional Holders
No institutional holder data.
Additional Fundamentals
Enterprise Value
$1.1B
Price/Book
11.96
Beta
0.913
Analysts
2
Total Revenue (TTM)
$86.3M
Earnings Growth
+22.1%
Dividend Yield
87.0%
Short Ratio
6.04
Short % Float
0.1%
Employees
166

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite
Trade Consideration
The Opportunity
Score 54.6 (P84 — top 15.7% of scored tickers). Unknown Moat. Ethical PASS. 2 analysts at None.
Price: $91.84 | Target: $118.00 (+28%)
Score
55
Moat
Unknown
Conviction
Standard
Upside
+28%
The Fundamentals
Revenue Growth+12.6%
Profit Margin27.4%
ROE25.0%
Forward P/E39.0
Market Cap$1.2B
Position Sizing Scenarios
Stop: $78.06 (-15%) | Entry: $91.84
SharesCostProfit to TargetR:R
To Consensus ($118.00, 2 analysts)
10$918.40+$261.60 (28%)1.9R
50$4,592.00+$1,308.00 (28%)1.9R
100$9,184.00+$2,616.00 (28%)1.9R
Risk Factors
  • Elevated short interest (6.04 days to cover)
  • Valuation stretched on forward earnings
The Verdict
IRADIMED CORPORATION passes all ethical screens and holds a unknown competitive moat.
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

A
Quant Score
71.4
Risk Grade
LOW_RISK
Layers
7
Quality: HIGH_SORTINO
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-2.7%
worst expected daily loss, 19 in 20 days
CVaR 95%
-4.0%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
2.08
above 1.0 is good
Max Drawdown
-22.1%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
60
Liquidity Grade
LIQUID
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
ABOVE_200
Bollinger Position
NEAR_UPPER
Beta
Relative Volume
1.4x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
IWM0.479
SXI0.467
ADJEX0.467
RVT0.437
VTI0.414
Inverse Correlated
TickerCorrelation
BAES.L-0.177
4326.SR-0.147
006400.KS-0.136
LUXCHEM.KL-0.135
LPTVQ-0.129
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Tuesday
Worst Day
Friday
Best Month
Nov
Worst Month
Apr
Fri-Mon Effect
-0.4779758948115914
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
+9.4%
3M Return
-9.8%
6M Return
+3.0%
12M Return
+77.9%
Momentum Rank
#1538
Momentum Signal
UP

Get our daily market read free. Join thousands of traders.

Free Explorer Access